» Articles » PMID: 26209539

Pancreatic Cancer Metastases Harbor Evidence of Polyclonality

Overview
Journal Cancer Discov
Specialty Oncology
Date 2015 Jul 26
PMID 26209539
Citations 163
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Studies of the cancer genome have demonstrated that tumors are composed of multiple subclones with varied genetic and phenotypic properties. However, little is known about how metastases arise and evolve from these subclones. To understand the cellular dynamics that drive metastasis, we used multicolor lineage-tracing technology in an autochthonous mouse model of pancreatic cancer. Here, we report that precursor lesions exhibit significant clonal heterogeneity but that this diversity decreases during premalignant progression. Furthermore, we present evidence that a significant fraction of metastases are polyclonally seeded by distinct tumor subclones. Finally, we show that clonality during metastatic growth-leading to either monoclonal or polyclonal expansion-differs based on the site of metastatic invasion. These results provide an unprecedented window into the cellular dynamics of tumor evolution and suggest that heterotypic interactions between tumor subpopulations contribute to metastatic progression in native tumors.

Significance: Studies of tumor heterogeneity indicate that distinct tumor subclones interact during cancer progression. Here, we demonstrate by lineage tracing that metastases often involve seeding by more than one clone and that subsequent cellular outgrowth depends on the metastatic site. These findings provide insight into clonal diversity and evolution in metastatic disease.

Citing Articles

Integrating model systems and genomic insights to decipher mechanisms of cancer metastasis.

Leung M, Swanton C, McGranahan N Nat Rev Genet. 2025; .

PMID: 40065153 DOI: 10.1038/s41576-025-00825-2.


Invasion and metastasis in cancer: molecular insights and therapeutic targets.

Li Y, Liu F, Cai Q, Deng L, OuYang Q, Zhang X Signal Transduct Target Ther. 2025; 10(1):57.

PMID: 39979279 PMC: 11842613. DOI: 10.1038/s41392-025-02148-4.


Implantation of engineered adipocytes suppresses tumor progression in cancer models.

Nguyen H, An K, Ito Y, Kharbikar B, Sheng R, Paredes B Nat Biotechnol. 2025; .

PMID: 39905264 DOI: 10.1038/s41587-024-02551-2.


Islands of genomic stability in the face of genetically unstable metastatic cancer.

Bowland K, Lai J, Skaist A, Zhang Y, Teh S, Roberts N PLoS One. 2024; 19(12):e0298490.

PMID: 39700179 PMC: 11658618. DOI: 10.1371/journal.pone.0298490.


Claudin 7 suppresses invasion and metastasis through repression of a smooth muscle actin program.

West J, Golloshi R, Cho C, Wang Y, Stevenson P, Stein-OBrien G J Cell Biol. 2024; 223(12).

PMID: 39320351 PMC: 11450322. DOI: 10.1083/jcb.202311002.


References
1.
Marusyk A, Tabassum D, Altrock P, Almendro V, Michor F, Polyak K . Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity. Nature. 2014; 514(7520):54-8. PMC: 4184961. DOI: 10.1038/nature13556. View

2.
Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

3.
Gerlinger M, Rowan A, Horswell S, Math M, Larkin J, Endesfelder D . Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012; 366(10):883-892. PMC: 4878653. DOI: 10.1056/NEJMoa1113205. View

4.
Friedl P, Locker J, Sahai E, Segall J . Classifying collective cancer cell invasion. Nat Cell Biol. 2012; 14(8):777-83. DOI: 10.1038/ncb2548. View

5.
Bardeesy N, Aguirre A, Chu G, Cheng K, Lopez L, Hezel A . Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc Natl Acad Sci U S A. 2006; 103(15):5947-52. PMC: 1458678. DOI: 10.1073/pnas.0601273103. View